Mohammad A Alfhili
Overview
Explore the profile of Mohammad A Alfhili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alajeyan I, Alsughayyir J, Alfhili M
Dose Response
. 2025 Jan;
23(1):15593258251314825.
PMID: 39823073
Cytokinins are plant hormones that regulate cell growth and differentiation. In particular, zeatin (ZTN) delays cellular senescence of human fibroblasts and keratinocytes and exhibits anticancer activity. Chemotherapy-induced anemia is a...
2.
Alharthy F, Alsughayyir J, Alfhili M
Folia Biol (Praha)
. 2024 Dec;
70(3):179-188.
PMID: 39644112
Docosahexaenoic acid (DHA) is an omega-3 polyunsaturated fatty acid with promising anticancer potential. Anaemia is a frequent adverse effect of anticancer treatment caused in part by eryptosis and haemolysis. Thus,...
3.
Alghareeb S, Alsughayyir J, Alfhili M
Toxicol Res (Camb)
. 2024 Nov;
13(6):tfae196.
PMID: 39600690
Objective: The agricultural herbicide 2,4-dichlorophenoxyacetic (2,4-D) is cytotoxic to human red blood cells (RBCs) by virtue of oxidative hemolysis. Nevertheless, there remains a great paucity of literature detailing the mechanisms...
4.
Alfhili M, Alghareeb S, Alotaibi G, Alsughayyir J
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596338
Anticancer drugs cause anemia in patients through eryptosis and hemolysis. We thus studied the in vitro toxicity of galangin (GAL) in red blood cells (RBCs). RBCs were exposed to 50-500...
5.
Alharthy F, Alsughayyir J, Alfhili M
Drug Chem Toxicol
. 2024 Oct;
:1-11.
PMID: 39478356
Anticancer medications cause anemia in patients through ill-defined mechanisms, including hemolysis and eryptosis. Although α-linolenic acid (ALA) possesses anticancer properties against a variety of cancer cells, there is a dearth...
6.
Alshuweishi Y, Alfayez D, Almufarrih A, Abudawood A, Alyami H, Alshuweishi F, et al.
J Clin Med
. 2024 Sep;
13(18).
PMID: 39337137
Obesity is a pathological condition and a major risk factor for dyslipidemia, type 2 diabetes, and non-alcoholic fatty liver disease. Recent research highlighted the association of non-invasive serum markers with...
7.
Aldawood E, Alzamil L, Dabbagh D, Hafiz T, AlHarbi S, Alfhili M
Medicina (Kaunas)
. 2024 Aug;
60(8).
PMID: 39202557
: Persistent high-risk Human Papillomavirus (HPV) can cause cancers in the cervix, vulva, vagina, anus, penis, and oropharynx. A lack of knowledge about HPV can lead to vaccine hesitancy, which...
8.
Alajeyan I, Alsughayyir J, Alfhili M
Yonago Acta Med
. 2024 Aug;
67(3):191-200.
PMID: 39176191
Background: Cedrol (CRL) is a sesquiterpene alcohol present in the essential oils of coniferous trees including and genera. CRL has shown potent anticancer activity by virtue of apoptosis. Red blood...
9.
Alghareeb S, Alsughayyir J, Alfhili M
Toxicol Pathol
. 2024 Aug;
52(5):284-294.
PMID: 39148410
Ginsenoside Rh2 (GRh2) exhibits significant potential as an anticancer agent; however, progress in developing chemotherapeutic drugs is impeded by their toxicity toward off-target tissues. Specifically, anemia caused by chemotherapy is...
10.
Basudan A, AlThani M, Abudawood M, Farzan R, Alshuweishi Y, Alfhili M
J Clin Med
. 2024 Mar;
13(6).
PMID: 38541877
Lymphomas account for approximately 10% of all cancer cases among the Saudi population. Even when separated, Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) are in the top ten most commonly...